restrictions curbing success of pharma groups of all sizes

Restrictions curbing success of pharma groups of all sizes

Amid a lacklustre picture in the market, domestic pharma giants are attempting to cut costs to weather the storm of COVID-19, while multinational corporations like F. Hoffmann-La Roche, AstraZeneca, and Novartis are making new preparations.
covid 19 vaccine trial paused after unexplained illness

Covid-19 vaccine trial paused after unexplained illness

Clinical trials of one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were "paused" Tuesday after a volunteer developed an unexplained illness.
digitalisation prompts evolution of healthcare

Digitalisation prompts evolution of healthcare

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
pharma firms aiming for gmp certificates

Pharma firms aiming for GMP certificates

Despite strict requirements, international pharma giants like Novartis, AstraZeneca, and Pfizer are rushing to complete all necessary procedures to receive the most sought-after GMP recognition for their manufacturing sites, signalling a hotter tender market in the months to come.
vice minister of health witnesses astrazeneca national phytopharma model partnership

Vice Minister of Health witnesses AstraZeneca-National Phytopharma model partnership

Vice Minister of Health Tran Van Thuan and representatives of the Ministry of Health on July 11 witnessed the signing of the pharmaceutical distribution partnership between National Phytopharma J.S.C and AstraZeneca Vietnam Co., Ltd.
new approach of diabetes management to protect kidney at early stage

New approach of diabetes management to protect kidney at early stage

The Ho Chi Minh City Diabetes and Endocrinology Association has just collaborated with AstraZeneca – a global, science-led biopharmaceutical company – to host a webinar on the significant benefits of SGLT2i class in type 2 diabetes management.
strong partnership to prevent ncds threats at an early stage

Strong partnership to prevent NCDs threats at an early stage

Sharing the same vision to help address non-communicable diseases at an early stage in Vietnam, the second consecutive year of Community Day was held successfully by the robust partnership of AstraZeneca, the Vietnam Young Physicians Association, and healthcare partners.
healthy lung delivers positive impact to asthma copd management

Healthy Lung delivers positive impact to Asthma & COPD management

Healthy Lung with its UMAC model is a prime example of how respiratory disease management can be made available to the grass-roots level in Vietnam. As national taskforces continue to expand this model, it is important to analyse the impact of the Healthy Lung programme's clinical benefits and cost-effectiveness.
astrazenecas health ties earn recognition

AstraZeneca’s health ties earn recognition

A global biopharmaceutical company has received the Award of Excellence from Vietnam’s Ministry of Health for its outstanding contributions in the ­prevention and treatment of cancer, as well as in the development of local healthcare system.
commitment to better healthcare

Commitment to better healthcare

British-Swedish multinational pharmaceutical, AstraZeneca, has recently announced a stellar $220 million investment in Vietnam. Nitin Kapoor, company president of AstraZeneca in Vietnam, shared with VIR’s Tuan Khanh the strategic objectives of this investment and how it will tie into the company’s activities in Vietnam.
take a chance on vietnam pm phuc wants swedish investment

Take a chance on Vietnam: PM Phuc wants Swedish investment

Vietnam hopes that Swedish investors and businesses will cooperate with and invest in the Southeast Asian nation, Prime Minister Nguyen Xuan Phuc has said.
astrazeneca scales up investment in vietnam

AstraZeneca scales up investment in Vietnam

The investment sum will support Vietnamese people’s health by accelerating healthcare capacity development, research and development, and talent development.    
innovation towards healthier vietnam

Innovation towards healthier Vietnam

For its 25th anniversary in Vietnam, AstraZeneca, a global science-led pharmaceutical company, is going to upgrade its considerable investment in research and development of innovative healthcare solutions. Nitin Kapoor, chief representative of AstraZeneca Singapore Pte., Ltd. in Vietnam, talked to VIR’s Bich Thuy about new partnerships to further support local healthcare needs in non-communicable diseases.